|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
Q2 FY2026
As of Dec 31, 2025
|
Q1 FY2026
As of Sep 30, 2025
|
Q4 FY2025
As of Jun 30, 2025
|
Q3 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Dec 31, 2024
|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jun 30, 2023
|
Q3 FY2023
As of Mar 31, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Sep 30, 2022
|
Q4 FY2022
As of Jun 30, 2022
|
Q3 FY2022
As of Mar 31, 2022
|
Q2 FY2022
As of Dec 31, 2021
|
Q1 FY2022
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Real estate assets held for sale, net (Note 3) | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Cash, cash equivalents and short-term investments | ||||||||||||||||||||
| Restricted cash (Note 3) | ||||||||||||||||||||
| Other assets (Note 4) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Distributions payable | ||||||||||||||||||||
| Accrued liquidation costs (Note 5) | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Net Assets in Liquidation | ||||||||||||||||||||
| Restricted for Qualifying Victims (Note 6) | ||||||||||||||||||||
| All Interestholders | ||||||||||||||||||||
| Total net assets in liquidation | ||||||||||||||||||||
Loading...
